Low & middle income | Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Low & middle income
Records
63
Source
Low & middle income | Immunization, measles (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980 7.58949925
1981 9.7949348
1982 10.7777991
1983 30.58416547
1984 34.56262022
1985 40.28851906
1986 40.80121883
1987 49.20759916
1988 59.47097995
1989 65.42181717
1990 71.48620644
1991 67.21725105
1992 68.03529005
1993 68.4583913
1994 69.68993261
1995 71.86488078
1996 71.47521674
1997 69.13556766
1998 68.57992217
1999 69.30233311
2000 69.83080931
2001 70.45494531
2002 69.93684627
2003 71.6099687
2004 73.68470185
2005 75.29440692
2006 77.15768696
2007 77.77296421
2008 79.46464446
2009 82.24758455
2010 83.11653725
2011 83.5058586
2012 83.08208858
2013 83.19526145
2014 83.52763921
2015 83.90982746
2016 84.26835251
2017 84.56275077
2018 85.75634846
2019 85.52053792
2020 82.93845959
2021 80.83929837
2022 82.63036278

Low & middle income | Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Low & middle income
Records
63
Source